AKT1 and Friedreich ataxia: Alternatively, the PT might have originated from a pre-existing FA harboring a MED12 mutation, that was overgrown by the malignant component driven by EGFR and AKT1 activation and loss of function of p53, in which MED12 mutation was not required any longer for tumor growth.